Avid Radiopharmaceuticals Clinical Trials
Sponsors / Avid Radiopharmaceuticals
According to ClinicalTrials.gov, Avid Radiopharmaceuticals has served as lead sponsor on 60 registered trials. Across the portfolio, 3 are in recruitment, 1 are active non-recruiting, and 49 have reached completion. 6 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. Across the portfolio, planned enrollment totals 9,147 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
60
Total Trials
3
Recruiting
1
Other Active
49
Completed
6
Terminated / Withdrawn
9,147
Total Enrollment
Termination reasons: Recruitment50% · Safety33% · Other17%
Recent Terminations
- Cardiac Amyloidosis"Low enrollment"
- Cognitive Decline"study terminated due to lower than expected enrollment"
- Alzheimer's Disease"Lower than expected enrollment"
- AD"Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals."
- Alzheimers Disease"Study was terminated in anticipation of transfer of ownership to Avid Radiopharmaceuticals."
- Type 1 Diabetes
Active Trials (1 total)
- Neurodegenerative Disease PHASE2/PHASE3NCT03143374
- NCT04708613
- NCT03019757
- NCT02958670